Search

Author/Creator Heffernan, T.P.

1. MEKi-based combination strategies for targeting KRAS-driven cancer. (October 2022)

Authors:
Kostyrko, K.; Hinkel, M.; Traexler, P.E.; Arnold, D.; Melo-Zainzinger, G.; Gerlach, D.; Ruzicka, R.; Jacob, R.; Baum, A.; Lu, H.; Vellano, C.P.; Marszalek, J.R.; Heffernan, T.P.; Tontsch-Grunt, U.; Hofmann, M.H.
Journal:
European journal of cancer
Issue:
Volume 174(2022)Supplement 1
Page Start:
S54
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Vertical pathway inhibition with a SOS1:KRAS inhibitor enhances the efficacy of KRAS G12C inhibitors, delays feedback resistance and demonstrates durable response. (October 2020)

Authors:
Savarese, F.; Gmachl, M.; Federico, L.; Trapani, F.; Gerlach, D.; Daniele, J.; Feng, N.; Bristow, C.A.; Machado, A.; Huang, J.; Rudolph, D.; Waizenegger, I.; Ramharter, J.; Vellano, C.P.; Petronczki, M.; Marszalek, J.R.; Heffernan, T.P.; McConnell, D.B.; Kraut, N.; Hofmann, M.
Journal:
European journal of cancer
Issue:
Volume 138(2020)Supplement 2
Page Start:
S22
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search